Nurix Therapeutics Inc NRIX

NAS: NRIX | ISIN: US67080M1036 21:48

12,75 USD (-2,56%)

(-2,56%) 21:48

Grafiek Nurix Therapeutics Inc

Grafiek Nurix Therapeutics Inc

1 dag1d -2,56%
1 week1w 3,11%
1 maand1m -14,23%
3 maanden3m 56,57%
6 maanden6m 129,43%
1 jaar1j 35,59%
5 jaar5j -32,96%

Nurix Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

16 maart 2021 · Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers · Persbericht

10 maart 2021 · Nurix Therapeutics Announces Presentation of NX-1607 Preclinical Data at AACR · Persbericht

9 maart 2021 · Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares · Persbericht

9 maart 2021 · Nurix Therapeutics to Participate and Present at Upcoming Investor Conferences · Persbericht

5 maart 2021 · Nurix Therapeutics Announces Pricing of Upsized Public Offering of Common Stock · Persbericht

2 maart 2021 · Nurix Therapeutics Announces Launch of Proposed Public Offering of Common Stock · Persbericht

16 februari 2021 · Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update · Persbericht

7 januari 2021 · Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies · Persbericht

Profiel Nurix Therapeutics Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Werknemers: 300

Aandelen Nurix Therapeutics Inc

Beurswaarde: 642,89 miljoen USD

Effecten: 49,15 miljoen

Winst per aandeel (12 maand): PLUS

Beta: 2,33

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe